Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali® (ribociclib) that underscore the extended efficacy beyond the duration of treatment in ...

Among patients with ER-positive/HER2-negative advanced breast cancer, treatment with camizestrant in combination with Kisqali ...

Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

Novartis NVS announced positive top-line results from a late-stage study on Fabhalta (iptacopan) in adult patients with ...

Kisqali (ribociclib) given alongside endocrine therapy as adjuvant therapy for patients with stage 2 or 3 hormone receptor-positive, HER2-negative breast cancer reduced patients’ risk for ...

Patients included in the trial had HR+/HER2– metastatic breast cancer, were 18 years or older, and started index treatment ...

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

The Israeli prime minister said its forces would remain in Syrian territory until “a new force” filled the vacuum. Secretary of State Antony J. Blinken was in Jordan for talks on the aftermath ...

South Africa sweep Sri Lanka 2-0 to lead World Test Championship table Maharaj’s five-for helps South Africa beat Sri Lanka by 109 runs and leap ahead of Australia and India on the WTC table ...